A CUTTING-edge research laboratory will open near Didcot today, specialising in neuroscience.

Ipsen BioInnovation will officially unveil its new research and development centre at Milton Park today, with special guests Baroness Blackwood and Wantage MP Ed Vaizey.

Expert research carried out there will focus on disorders of the brain, spinal cord and nerves, with a wider remit to investigate medicines in oncology and rare diseases.

Sarah Haywood, managing director at Advanced Oxford, will also be attending as well as NHS stakeholders and senior members of the Ipsen UK team.

ALSO READ: Milton Park sets out its vision for 2040

The new research centre is part of a £12m investment by Ipsen into its facilities at Milton Mark in the past year.

It employs more than 80 people including 40 research scientists.

John Chaddock, vice president of neurology and site head at Ipsen BioInovation, said: "I am extremely proud of our team of highly skilled scientists and researchers who oversee industry-leading work in the field of neuroscience at Milton Park.

"Within the last four years Ipsen has invested over £150million across our three UK sites.

"Through this continued development of our research facilities at Milton Park, we are working relentlessly in the discovery and development of new compounds designed to treat disease and improve quality of life for patients."